english version deutsche Version

Professor Dr. Hans-Ulrich Wittchen

Guest Professer on the Institute of Clinical Psychology and Psychotherapy
Previous Institute Director
Technische Universität Dresden
Chemnitzer Str. 46
D-01187 Dresden

Tel:  ++49-351-463-36985
Fax:  ++49-351-463-36984
e-mail: hans-ulrich.wittchen@tu-dresden.de

more photos


    Magazin Focus-Gesundheit 07/2017 Vol. 40 - Ärzteliste
    Prof. Hans-Ulrich Wittchen is a anxiety disorder expert.

    Thomson Reuters - Highly Cited Researcher 2016
      Great News - Thomson Reuters - 2016 Highly Cited Researcher
      Thomson Reuters congratulated Prof. Hans-Ulrich Wittchen to being on named a 2016 Highly Cited Researcher and to announce the availability of the official 2016 list

      He is selected as a Highly Cited Researcher because his work has been identified as being among the most valuable and significant in the field. Very few researchers earn this distinction - writing the greatest number of reports, officially designated by Essential Science Indicators as Highly Cited Papers. In addition, these reports rank among the top 1% most cited works for their subject field and year of publication, earning them the mark of exceptional impact.
      more Information

Research Profile:

  • Diagnostic classification of mental disorders
  • Psychopathology,Diagnostic assessment instruments
  • Etiology and pathogenesis (clinical and experimental)
  • Therapy research (behavior therapy)
  • Clinical Epidemiology and services research
  • Addiction, Anxiety, Depression
  • Behavioral medicine: hypertension, diabetes, CHD, dementia, Parkinson´s Disease, Multiple Sclerosis

Curriculum Vitae

International Journal of Methods
in Psychiatric Research

Institute Report 2013-2014

Curriculum Vitae

Dr. Wittchen, born 1951 in Bad Salzuflen (Germany), was trained in Medicine and Psychology at the University of Vienna (Austria) where he completed his PhD dissertation in 1975. He began his career at the Ludwig Boltzmann Institute for Addiction Research (Vienna: 1974-1976). His career continued at the Central Institute of Mental Health (Mannheim: 1976) and then at the Max-Planck-Institute of Psychiatry (Muenchen) where he held positions as project-director for the research program "Psychotherapy in Germany" (1977 - 1980), head of the Department "Evaluation- and Clinical Epidemiology" at the Max-Planck-Institute of Psychiatry and director of the Munich Follow-up Study (MFS) (1980-1989). Dr. Wittchen obtained his habilitation at the LMU (München: 1984) and was appointed as Professor (C-3, tenure) of Clinical Psychology and Psychotherapy at the University of Mannheim. 1989 he worked as visiting professor in Geneva (ICD-10, diagnostic instruments). 1990 he was awarded tenure at the Max-Planck-Institute of Psychiatry (München: 1990-2000), directing the "Clinical Psychology and Epidemiology Department". In the time period between 1981 and 2000 Dr. Wittchen spent almost every year 3-month periods as visiting scientist and visiting professor at the US-National Institutes of Mental Health (NIMH), Washington University in St. Louis, Michigan University in Ann-Arbor and Harvard University in Boston to work on joint projects with distinguished researchers like Dr. Lee Robins, Dr. R.C. Kessler, Dr. D. Regier, Dr. J. Burke, and Dr. G. Klerman and M. Weissman.

Since 2000, Dr. Wittchen is director of the Institute of Clinical Psychology and Psychotherapy at the Technische Universität Dresden, including the Center of Clinical Epidemiology and Longitudinal Studies (CELOS) and the Clinical Outpatient and Day-Care Centre for Psychotherapy (IAP-TU Dresden GmbH).

Professor Wittchen is and has been principal investigator and co-investigator of many national and international research programs and large-scale epidemiological studies. His work encompasses a wide range of etiological-pathogenetic, family-genetic, experimental, clinical and epidemiological studies with a focus on prospective-longitudinal studies in addiction, anxiety, mood and somatic disorders. He has been instrumental in developing sophisticated concepts of comorbidity, the derivation of symptom progression models, the derivation of new behavioral treatment methods and translational research. More recently, his work has also extended into behavioral medicine by examining the interrelationship between mental disorders and a wide range of somatic and neurologic conditions, including cardiac diseases, diabetes, Parkinson's disease and Multiple Sclerosis.

Professor Wittchen has published over 820 peer-reviewed articles and is author of a number of text books (e.g., Text book of Clinical Psychology and Psychotherapy) and diagnostic instruments (e.g., Composite International Diagnostic Instrument, CIDI)and listed as "Highly Cited Researcher 2015" from Thomson Reuters. He is editor or on the editorial board of many leading peer-reviewed journals including Addiction, Drug and Alcohol Dependence, Psychological Medicine, Behavioral Psychotherapy, International Journal of Methods in Psychiatric Research, Acta Psychiatrica Scandinavica, Diagnostica, and Verhaltenstherapie. He is also a member of many international groups such as the Cross-National Group, WHO-CIDI Advisory and Editorial Committee, International Consortium of Psychiatric Epidemiology, World Mental Health Survey Consortium; he is also member of the Anxiety, Stress and OCD Task Forces for DSM-V and serves as advisor for the revision of the ICD-11. He is "APS Fellow" for "exceptional contributions to field" from the Association for Psychological Science APS (2016)and a member of the Editorial Board of ISI-WOS HIGH IMPACT Journals " World Psychiatry", Dr. Wittchen also serves as Speaker of the BMBF Addiction Research Network ASAT, Director of the BMBF Psychotherapy "Panic Network" and is council member of the European College of Neuropsychopharmacology (ECNP) and member of the steering board of the European Brain Council (EBC).
2014 he was Speaker (with Michael Bauer) of the German Mental Health Research Network Programm(BMBF) and Speaker of Providing Tools for Effective Care and Treatment of Anxiety Disorders(PROTECT-AD).